FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / SPONSORED ADS
Total 13F shares
11,303,478
Share change
-466,831
Total reported value
$91,623,000
Price per share
$8.15
Number of holders
16
Value change
-$4,785,853
Number of buys
3
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q2 2021

As of 30 Jun 2021, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,303,478 shares. The largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, Novo Holdings A/S, WELLINGTON MANAGEMENT GROUP LLP, CHI Advisors LLC, Polygon Management Ltd., Sectoral Asset Management Inc, AXA S.A., FRAZIER MANAGEMENT LLC, Ally Bridge Group (NY) LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.